Found: 22
Select item for more details and to access through your institution.
Low CD4 counts predict excessive weight gains during first-line treatment for HIV.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2369, doi. 10.1093/jac/dkae238
- By:
- Publication type:
- Article
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 3, p. 1, doi. 10.1093/ofid/ofae007
- By:
- Publication type:
- Article
Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTG.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 8, p. 1492, doi. 10.1093/cid/ciac949
- By:
- Publication type:
- Article
Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e3902, doi. 10.1093/cid/ciaa1073
- By:
- Publication type:
- Article
Participants on Dolutegravir Resuppress Human Immunodeficiency Virus RNA After Virologic Failure: Updated Data from the ADVANCE Trial.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 4, p. e1008, doi. 10.1093/cid/ciab086
- By:
- Publication type:
- Article
Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Coronavirus Host Genomics Study: South Africa (COVIGen-SA).
- Published in:
- Global Health, Epidemiology & Genomics, 2022, p. 1, doi. 10.1155/2022/7405349
- By:
- Publication type:
- Article
Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 12, p. 1, doi. 10.1093/ofid/ofac587
- By:
- Publication type:
- Article
Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV.
- Published in:
- Southern African Journal of HIV Medicine, 2022, v. 23, n. 1, p. 1, doi. 10.4102/sajhivmed.v23i1.1452
- By:
- Publication type:
- Article
Integration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africa.
- Published in:
- BMC Public Health, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12889-023-17190-6
- By:
- Publication type:
- Article
Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa.
- Published in:
- Journal of the International AIDS Society, 2024, v. 27, n. 7, p. 1, doi. 10.1002/jia2.26268
- By:
- Publication type:
- Article
The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South Africa.
- Published in:
- BMC Public Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12889-024-19253-8
- By:
- Publication type:
- Article
Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors.
- Published in:
- BMC Infectious Diseases, 2010, v. 10, n. 1, p. 83, doi. 10.1186/1471-2334-10-83
- By:
- Publication type:
- Article
Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 5, p. 1247, doi. 10.1111/bcp.16009
- By:
- Publication type:
- Article
Concentration–response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 3, p. 883, doi. 10.1111/bcp.15177
- By:
- Publication type:
- Article
Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 6, p. 821, doi. 10.1002/psp4.12955
- By:
- Publication type:
- Article
WEIGHT LOSS AND METABOLIC CHANGES AFTER SWITCHING FROM TAF/FTC/ DTG TO TDF/3TC/DTG.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 264
- By:
- Publication type:
- Article
High individual pain variability in people living with HIV: A graphical analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 3110, doi. 10.1093/jac/dkac290
- By:
- Publication type:
- Article
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 10, p. 2706, doi. 10.1093/jac/dkac266
- By:
- Publication type:
- Article
Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.
- Published in:
- Frontiers in Reproductive Health, 2023, v. 5, p. 1, doi. 10.3389/frph.2023.1133556
- By:
- Publication type:
- Article